REGENXBIO INC
RGNX·75901B107·US·Common Stock·Healthcare - Biotechnology-13D/G
RGNX (REGENXBIO INC) is held by 104 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($48.5M), JPMORGAN CHASE & CO ($27.1M), STATE STREET CORP ($22.9M). Net institutional sentiment: Mixed.
104
Holders
(10 Elite)
$271.8M
Total Value
54% (105)
Consensus
57 buying - 48 selling
13F: Insider & Congress:
Who's Trading
InsiderPSPAKOLA STEVESell $53KMar 10, 2026
ActivistBPBlackRock Portfolio Management LLC4.1%Jan 21, 2026
InsiderSCSimpson CurranSell $263KOct 9, 2025
InsiderSCSimpson CurranSell $76KSep 29, 2025
InsiderSCSimpson CurranSell $77KSep 10, 2025
ActivistRERedmile Group, LLC9.9%Aug 14, 2025
Top Holders
Showing 1-20 of 114
1 / 6
Continue exploring
Other Healthcare stocks held by institutions
413 holders · $666.6B
413 holders · $186.3B
394 holders · $391.3B
392 holders · $97B
391 holders · $123.5B
391 holders · $147B
389 holders · $76.8B
385 holders · $208.9B
381 holders · $254.9B
380 holders · $129.1B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer